22-Year-old patient with malignant hypertension associated with primary aldosteronism.
2013
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik
Department of Hypertension, Institute of Cardiology, Warsaw, Poland. prejbisz@vp.pl
UI
MeSH Term
Description
Entries
D006974
Hypertension, Malignant
A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
Malignant Hypertension
D003937
Diagnosis, Differential
Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures.
Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929
Hyperaldosteronism
A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA.
A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available.
Adults
Related Publications
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik
December 1963,
The New England journal of medicine,
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik
August 1966,
The Journal of clinical endocrinology and metabolism,
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik
January 1978,
Wiadomosci lekarskie (Warsaw, Poland : 1960),
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik
A Prejbisz, and
A Klisiewicz, and
A Januszewicz, and
J W Lenders, and
B Pręgowska-Chwała, and
K Jóźwik-Plebanek, and
I Michałowska, and
M Januszewicz, and
P Andziak, and
P Hoffman, and
T J Guzik